-
Something wrong with this record ?
World Marrow Donor Association guidelines for the reporting of novel HLA alleles
JA. Hofmann, W. Bochtler, J. Robinson, J. Sauter, M. Askar, L. Houdova, M. Melchers, AH. Schmidt, E. Spierings, C. Urban, A. Venter, M. Maiers, SGE. Marsh, HP. Eberhard
Language English Country England, Great Britain
Document type Journal Article
PubMed
37038092
DOI
10.1111/tan.15048
Knihovny.cz E-resources
- MeSH
- Alleles MeSH
- HLA Antigens genetics MeSH
- Bone Marrow * MeSH
- Humans MeSH
- Histocompatibility Testing MeSH
- Hematopoietic Stem Cell Transplantation * MeSH
- High-Throughput Nucleotide Sequencing MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
The guidelines for the implementation and reporting of HLA nomenclature for the World Marrow Donor Association have served as a reliable standard for communication of HLA data in the hematopoietic cell transplantation process. Wider use of next-generation sequencing made a special provision of the guidelines increasingly pertinent: how to communicate novel HLA alleles. Novel alleles need to be recognized by the WHO Nomenclature Committee for Factors of the HLA system to obtain official allele designations. Until then they have to be handled according to the specific rules. Leaving the actual rules basically unchanged we give some advice on how to communicate novel alleles to best facilitate the search process for cases where novel alleles are identified on donor or patient side.
Anthony Nolan Research Institute and UCL Cancer Institute Royal Free Campus London UK
Center of Translational Immunology University Medical Center Utrecht Utrecht the Netherlands
College of Medicine Qatar University Doha Qatar
NMDP Minneapolis Minnesota USA
NTIS University of West Bohemia Pilsen Czechia
World Marrow Donor Association WMDA Office Leiden the Netherlands
Zentrales Knochenmarkspender Register Deutschland Ulm Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010928
- 003
- CZ-PrNML
- 005
- 20230801132712.0
- 007
- ta
- 008
- 230718s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/tan.15048 $2 doi
- 035 __
- $a (PubMed)37038092
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hofmann, Jan A $u DKMS, Tübingen, Germany $1 https://orcid.org/0000000233972514
- 245 10
- $a World Marrow Donor Association guidelines for the reporting of novel HLA alleles / $c JA. Hofmann, W. Bochtler, J. Robinson, J. Sauter, M. Askar, L. Houdova, M. Melchers, AH. Schmidt, E. Spierings, C. Urban, A. Venter, M. Maiers, SGE. Marsh, HP. Eberhard
- 520 9_
- $a The guidelines for the implementation and reporting of HLA nomenclature for the World Marrow Donor Association have served as a reliable standard for communication of HLA data in the hematopoietic cell transplantation process. Wider use of next-generation sequencing made a special provision of the guidelines increasingly pertinent: how to communicate novel HLA alleles. Novel alleles need to be recognized by the WHO Nomenclature Committee for Factors of the HLA system to obtain official allele designations. Until then they have to be handled according to the specific rules. Leaving the actual rules basically unchanged we give some advice on how to communicate novel alleles to best facilitate the search process for cases where novel alleles are identified on donor or patient side.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kostní dřeň $7 D001853
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a HLA antigeny $x genetika $7 D006680
- 650 _2
- $a testování histokompatibility $7 D006650
- 650 12
- $a transplantace hematopoetických kmenových buněk $7 D018380
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bochtler, Werner $u Zentrales Knochenmarkspender-Register Deutschland (ZKRD), Ulm, Germany $1 https://orcid.org/0009000596965708
- 700 1_
- $a Robinson, James $u Anthony Nolan Research Institute, and UCL Cancer Institute, Royal Free Campus, London, UK $1 https://orcid.org/0000000221875944
- 700 1_
- $a Sauter, Jürgen $u DKMS, Tübingen, Germany $1 https://orcid.org/0000000184852945
- 700 1_
- $a Askar, Medhat $u College of Medicine, Qatar University, Doha, Qatar $u NMDP, Minneapolis, Minnesota, USA $1 https://orcid.org/0000000326339363
- 700 1_
- $a Houdova, Lucie $u NTIS, University of West Bohemia, Pilsen, Czechia $1 https://orcid.org/0000000242499511
- 700 1_
- $a Melchers, Mark $u World Marrow Donor Association-WMDA Office, Leiden, the Netherlands $1 https://orcid.org/0009000124541165
- 700 1_
- $a Schmidt, Alexander H $u DKMS, Tübingen, Germany $1 https://orcid.org/0000000309795914
- 700 1_
- $a Spierings, Eric $u Center of Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands $1 https://orcid.org/0000000194411019
- 700 1_
- $a Urban, Christine $u DKMS, Tübingen, Germany $1 https://orcid.org/0009000554851761
- 700 1_
- $a Venter, Alicia $u World Marrow Donor Association-WMDA Office, Leiden, the Netherlands $1 https://orcid.org/0009000719405277
- 700 1_
- $a Maiers, Martin $u NMDP, Minneapolis, Minnesota, USA $1 https://orcid.org/0000000201982064
- 700 1_
- $a Marsh, Steven G E $u Anthony Nolan Research Institute, and UCL Cancer Institute, Royal Free Campus, London, UK $1 https://orcid.org/0000000328554120 $7 xx0090205
- 700 1_
- $a Eberhard, Hans-Peter $u Zentrales Knochenmarkspender-Register Deutschland (ZKRD), Ulm, Germany $1 https://orcid.org/0000000227314486
- 773 0_
- $w MED00195031 $t HLA $x 2059-2310 $g Roč. 102, č. 1 (2023), s. 62-64
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37038092 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132708 $b ABA008
- 999 __
- $a ok $b bmc $g 1963381 $s 1197193
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 102 $c 1 $d 62-64 $e 20230410 $i 2059-2310 $m HLA $n HLA $x MED00195031
- LZP __
- $a Pubmed-20230718